Clinical Trial Update: P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating P53 mutational status and circulating cell-free HPV DNA as biomarkers to guide management of HPV-associated oropharyngeal sq…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Carcinoma, Squamous Cell, Head and Neck Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2024-05-02